STUDresearch · Non-peptide
Bromantane
Also known as
Ladasten · NP-160 · bromantan
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Non-peptide
Niche talk
Systemic
Oral
Cognitive / nootropic peptides
Systemic oral actoprotector / neuromodulator discussion.
What people say
Bromantane is discussed as a Russian actoprotector with a smoother motivation profile than classic stimulants. Community descriptions remain variable and product-dependent.
Doses people talk about
The range is descriptive, not a personal starting point; route, formulation and regional product labeling matter.
How it may feel
Accounts range from no clear benefit to subtle multi-day drive, sleepiness or marked insomnia. Route, amount and repeated use differ enough that there is no single first-week script.
English-language oral chart~50–100 mg oral
Repeated in biohacking discussions; it is not validated by the anecdotal response range.
Translated Ladasten label50–100 mg single dose; 100–200 mg/day in two doses for 2–4 weeks
Third-party English translation of a regional product insert; not a global OTC standard or a personal regimen.
Half-life & effect duration
- Half-life in the body
- OralAbout 11 hours
- Felt duration people report
- Positive accountsAll-day drive; sometimes a day or two of buildup or a multi-day motivation lift
- Other accountsNo benefit, sleepiness, insomnia or disrupted sleep
Cycles people discuss
Weeks-on followed by time off is the common discussion pattern, but no universal cycle is established. Reports also include stopping after poor response or sleep problems.
Timing
Oral schedules differ between community charts and the translated Ladasten insert, which describes two doses daily. Community timing notes focus on sleep, training and side effects rather than a fixed clock time.
Stacks
Nootropic and racetam stacks are common in discussion. Co-use makes motivation, mood and sleep changes harder to attribute.
Watch for
Insomnia / overstimulation: If dosed late or high.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
A translated Ladasten insert reports an 11.21-hour half-life after oral dosing.
The insert also reports 2–4-hour Tmax; a review reports 42% oral bioavailability and mean Tmax of 2.75 hours in women and 4 hours in men.
The insert is a third-party translation and the review relies on older Russian literature; neither is a modern independent replication or a felt-duration study.
- Ladasten instructions for medical use — English translation (opens in a new tab)Pharmacokinetics and dosage sections: Cmax 363.3 ng/ml, Tmax 2–4 h, half-life 11.21 h and labeled tablet schedule.Third-party English rendering of a Russian insert; not an independent peer-reviewed PK report or subjective-effect study.
- The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance (opens in a new tab)Review pharmacokinetics section: 42% oral bioavailability, mean Tmax 2.75 h in women and 4 h in men, slow elimination and metabolite detection context.Secondary review drawing on older studies; it does not establish a modern independent half-life or subjective duration.
Felt duration people report
The inspected reports conflict on both direction and duration of felt effects.
Reports include no benefit, a day or two of buildup, all-day drive, sleepiness and insomnia; a later report described sleep fragmentation on repeated use and after one re-challenge.
Unverified products, different routes and amounts, retrospective reporting, co-use and sleep baselines prevent a dependable duration estimate.
- Bromantane experience (opens in a new tab)Original post and visible replies: oral, sublingual and intranasal use; no benefit, buildup, exercise and insomnia reports.Different users, routes, products and co-supplements; no verification or standardized outcomes.
- Sleep on Bromantane (opens in a new tab)Original post and visible comments: morning oral/sublingual/nasal amounts with mutually conflicting sleepiness and insomnia reports.Anonymous self-reports, mixed routes and amounts, unverified products and no sleep measurement.
- Sleep issues from Bromantane (opens in a new tab)bubba123412 original post and same-author follow-ups: 100 mg daily for two months, sleep fragmentation from week three, two-month stop and single-dose re-challenge.Single retrospective report; unverified product, later ashwagandha use and unresolved ongoing insomnia complicate causality.
What people say
- Training drive: Anecdotes of better workout motivation without heavy jitter. anecdote
- Focus / clarity talk: Bromantane shows up in threads about attention, mental fatigue, or “brain fog” days. forum
- Mood adjacency: Some logs mention motivation or anxiety edge changes — highly confounded by caffeine/sleep/stim stacks. anecdote
- Acute vs course: Nasal/SC nootropics often judged same-day; multi-week courses are for “is this real” reassessment. forum
- Asthenia / fatigue: Clinical and post-Soviet medical literature discusses use in asthenic conditions. trial
Doses people talk about
- Two oral evidence lanes: English-language community charts often name ~50–100 mg oral; the translated Ladasten insert reports 50–100 mg as a single dose and 100–200 mg/day divided into two doses for 2–4 weeks. These are descriptive, source-specific amounts, not a personal regimen. forumtrial
- Quality flag: Assume label accuracy only if analytically verified — gray market fill error is common. forum
- Product quality: Gray-market fill accuracy and identity are uncertain; dose math assumes the label is true. forum
- Route changes the math: Oral vs SC vs nasal are not interchangeable milligram-for-milligram stories. forum
- Oral charts: Often ~50–100 mg oral in English biohack threads; Ladasten regional regimens differ. forum
- Framing: Not a standardized global OTC supplement dose. forum
- Start conservative (community): When people experiment, they often start at the low end of a charted band to gauge tolerance — still not advice. forum
How it may feel
- Early reports vary: Oral, sublingual and nasal self-reports range from no noticeable benefit to all-day drive, sleepiness or insomnia; they do not support the earlier injection-site template as a typical first-week Bromantane sequence. forum
- Days 1–7: Subtle for many; not a party stimulant kick. forum
- Weeks 2–4: Common self-experiment window. forum
- Subtle: Not a pre-workout bang; logs that like it describe multi-day “want to do things” more than a 30-minute peak. anecdote
Cycles people discuss
- Blocks: Often weeks-on then off to reassess tolerance. forum
- Common pattern: Many self-protocols use weeks-on / weeks-off rather than indefinite daily use — cost and caution drive this more than hard science. forum
- No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
- Reassess: Stop and reassess if adverse effects appear; this is not medical care. forum
Timing
- Timing practicalities: People time doses around side effects, training, and sleep more than perfect PK. forum
- Acute window: Nasal/SC nootropics are often judged within hours; true half-life data may be sparse for analogs. forum
- Published/label PK context: A translated Ladasten insert reports an 11.21-hour half-life and 2–4-hour Tmax after oral dosing; a review reports 42% oral bioavailability and sex-specific Tmax values. These sources do not establish one felt-effect window. trial
More on what it is
- Why people care: Non-classical stimulant lore — dopaminergic/serotonergic enzyme talk without caffeine-like crash narratives. forum
- Research posture: Educational summary of public discussion and literature themes only. forum
- Bro framing: “Smooth drive” actoprotector — motivation without classic stim jitters in user stories. forum
- What it is: Adamantane-family actoprotector (Ladasten in some markets) discussed for fatigue, anxiety-adjacent drive, and “smooth stimulation.” trial
- Not a peptide: Non-peptide small molecule. trial
- Research only: Not approved advice for self-experimentation; legality and access vary by place. forum
Stacks
- With racetams / nootropics: Common stack talk; confounded. forum
- Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- Insomnia / overstimulation: If dosed late or high. forum
- Headache: Occasional. anecdote
- Injection site (if injected): Redness, itch, lumps, bruise — technique and product quality matter. forum
- Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
- Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
- Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.